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ABSTRACT
Alcohol and drug use disorders are individually heritable (50%). Twin studies indicate that alcohol and substance
use disorders share common genetic influences, and therefore may represent a more heritable form of addiction and
thus be more powerful for genetic studies. This study utilized data from 2322 subjects from 118 European-American
families in the Collaborative Study on the Genetics of Alcoholism sample to conduct genome-wide association analy-
sis of a binary and a continuous index of general substance dependence liability. The binary phenotype (ANYDEP)
was based on meeting lifetime criteria for any DSM-IV dependence on alcohol, cannabis, cocaine or opioids.
The quantitative trait (QUANTDEP) was constructed from factor analysis based on endorsement across the seven
DSM-IV criteria for each of the four substances. Heritability was estimated to be 54% for ANYDEP and 86% for
QUANTDEP. One single-nucleotide polymorphism (SNP), rs2952621 in the uncharacterized gene LOC151121 on
chromosome 2, was associated with ANYDEP (P = 1.8 × 10−8), with support from surrounding imputed SNPs and
replication in an independent sample [Study of Addiction: Genetics and Environment (SAGE); P = 0.02]. One SNP,
rs2567261 in ARHGAP28 (Rho GTPase-activating protein 28), was associated with QUANTDEP (P = 3.8 × 10−8),
and supported by imputed SNPs in the region, but did not replicate in an independent sample (SAGE; P = 0.29). The
results of this study provide evidence that there are common variants that contribute to the risk for a general liability
to substance dependence.
Keywords Alcohol dependence, cannabis dependence, cocaine dependence, common genetic liability, drug
dependence, opioid dependence.
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INTRODUCTION
An estimated 15.3million adults in the United States met
criteria for an alcohol use disorder in the past 12months.
Of those with alcohol use disorders, 2.3 million adults
also met criteria for a drug use disorder (Stinson et al.
2005) with odds ratios estimated to be 7.4 for any drug
use disorder, but 3.4 to 19.2 for specific drug use disor-
ders (Stinson et al. 2005; Khan et al. 2013). Both alcohol
and drug use disorders are heritable, with approximately
50% of the variance attributable to heritable factors
(Tsuang et al. 1998; Bienvenu, Davydow&Kendler 2011;
Ducci & Goldman 2012; Wang, Kapoor & Goate 2012),
although this estimate varies dramatically by substance
(e.g. up to 70% heritability for cocaine dependence;
Kendler et al. 2000), age (Bergen, Gardner & Kendler
2007; Derringer et al. 2008; Vrieze et al. 2012) and other
characteristics, including co-morbid psychopathology
(Pickens et al. 1991).
This heritable variation can be parsed into those
genetic influences that are specific to each drug and
importantly, those genetic factors that confer a general
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predisposition to alcohol and/or substance use disorders,
and even other disinhibited behaviors (Krueger et al.
2002; Hicks et al. 2013). Two large twin studies have
convincingly shown that a preponderance of the genetic
factors influencing illicit drug use disorders overlap
(Tsuang et al. 2001; Kendler et al. 2003). Noticeably,
when these models were extended to include alcohol use
disorders, there was evidence for highly correlated
genetic factors (r = 0.82) that individually influenced the
covariation in alcohol and nicotine dependence as well as
cannabis and cocaine dependence (Kendler, Myers &
Prescott 2007). The extent of genetic overlap was strong
for some substances—for instance, 55% and 24% of the
genetic variance in alcohol dependence was due to the
licit and illicit drug factors, respectively, with the remain-
der being substance specific. In contrast, for nicotine
dependence, 63% of the genetic variance was drug spe-
cific (with 26% and 11% attributable to heritable varia-
tion in the licit and illicit factors, respectively). Similar to
the individual heritability of each substance, there is
growing evidence that the heritable covariation across
substances changes across development (Young et al.
2006; Vrieze et al. 2012). Irrespective of development
and substance-specific variation, there is broad consen-
sus that gene discovery efforts targeting aggregate
genetic variation that indexes a shared liability to a
variety of substance use disorders, as well as disinhi-
bition, can be profitable (McGue et al. 2013; Vrieze et al.
2014), with one study showing evidence for genome-
wide pleiotropic effects across substance use disorders
(Vrieze et al. 2013).
There are multiple approaches, both phenotypic and
genetic, to capture the commonality underlying alcohol
and substance use disorders and the present study utilizes
two straightforward phenotypic approaches.We opted for
simple dependence-based phenotypic traits as they lend
themselves to replication and future meta-analysis. First,
we utilized a binary phenotype, with affection status
defined as meeting dependence criteria for at least one
substance (alcohol, cannabis, cocaine or opioids), termed
ANYDEP. Second, we used factor analysis to combine
dependence criteria across substances into a continuous
quantitative trait representing vulnerability to multiple
substance dependence, termed QUANTDEP. This quanti-
tative measure is heritable (approx. 60%; Palmer et al.
2012) and has previously been used in genomic studies
(Yang et al. 2012), the most recent of which utilized a
similar expanded factorial measure of behavioral dis-
inhibition (including alcohol, nicotine, cannabis and
other illicit drug use disorders) to conduct genome-wide
association and rare nonsynonymous variant analyses
(McGue et al. 2013; Vrieze et al. 2014). These studies did
not identify any single common or rare variant at a
genome-wide significant level; however, the authors
reported that 84% of the heritability in illicit drug use
was explained by both common and rare variants. While
the work of McGue and colleagues included multiple
measures of nicotine use and dependence, we elected to
exclude nicotine from these measures of general liability
based on the work by Kendler and colleagues (Kendler
et al. 2007), which showed significant drug-specific
genetic influences on nicotine dependence.
In this study, we utilized data from 2322 subjects
from 118 families of European-American descent ascer-
tained for alcohol dependence liability to conduct
genome-wide association analysis (GWAS) of a binary
and a continuous index of general substance depend-
ence liability. While some prior genome-wide efforts
(McGue et al. 2013) have utilized similar phenotypes in
population samples of related individuals, the ascertain-
ment strategy and extended family-based design in our
study should increase our ability to detect genetic varia-
tion in this phenotype. First, there is substantial evi-
dence that alcohol use disorders that co-aggregate with
other substance use disorders (Khan et al. 2013) may
represent a more heritable form of addiction (Pickens
et al. 1991). Secondly, by modeling the strength of the
phenotypic correlation across different degrees of
genetic relatedness (i.e. kinship), we utilize data on all
related individuals, even those not meeting criteria for
diagnoses, allowing us to better explore the extent of
co-aggregation of genetic risk across alcohol, cannabis,
cocaine and opioid dependence.
MATERIALS AND METHODS
Sample
Six sites participating in the Collaborative Study on the
Genetics of Alcoholism (COGA) (Begleiter et al. 1995;
Foroud et al. 2000) recruited alcohol-dependent pro-
bands from in-patient and outpatient facilities. The
probands and their family members were administered a
poly-diagnostic interview, the Semi-Structured Assess-
ment for the Genetics of Alcoholism (SSAGA) (Bucholz
et al. 1994; Hesselbrock et al. 1999). Individuals 17 years
of age or younger were administered an adolescent
version of the SSAGA. Institutional review boards at all
sites approved the study.
A subset of the most genetically informative families
was selected for a family-based GWAS. This sample has
been described in detail elsewhere (Kang et al. 2012;
Wang et al. 2013) but salient characteristics are pre-
sented here. Families were prioritized based on the
number of family members with: (1) available DNA who
were also alcohol dependent; (2) available DNA who also
had electrophysiology data; and (3) available DNA,
regardless of other phenotypes. To reduce heterogeneity,
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only families consisting primarily of self-reported
European-American ethnicity were included in the
sample. The final sample was comprised of 118 large
European-American families consisting of 2322 indi-
viduals with available DNA.
Phenotypes and statistical analysis
Phenotype data for four substances (alcohol, cannabis,
cocaine and opioids) were obtained from the SSAGA.
Some individuals were assessedmore than once, in which
case data from the SSAGA interview at which an indi-
vidual reported themaximumnumber of DSM-IV criteria
endorsements for the particular substance was used.
Two phenotypes were used in the genetic analyses:
ANYDEP, a binary aggregate substance dependence
phenotype, and QUANTDEP, a quantitative (continuous)
substance dependence phenotype developed using factor
analysis.
For ANYDEP, individuals were considered affected if
they met DSM-IV lifetime dependence criteria for any of
the four substances, and unaffected if they did not meet
DSM-IV dependence criteria for all four drugs. Individuals
younger than 23 years old at their most recent interview
who did not meet criteria for dependence on any of the
four drugs were recoded to missing/unknown (n = 408)
because they had not passed through the primary age of
risk. Selection of this age cutoff was based on the median
age of onset of alcohol, cannabis, cocaine and opioid/
heroin dependence in the White subsample of the US
population-based National Epidemiologic Survey of
Alcohol and Related Conditions (Grant et al. 2004;
Hingson, Heeren & Winter 2006). The median ages
ranged from 18 to 22 years, supporting a cut-off of 23
years. In addition, those individuals with insufficient
SSAGA to determine whether they were or were not
dependent were also coded as unknown (n = 144).
QUANTDEP, the quantitative factor score, was con-
structed by conducting a confirmatory factor analysis of
the seven DSM-IV lifetime dependence criteria (coded as
present or absent) for each of the four substances (28
items total). As wewere interested in those genetic under-
pinnings that were common to all dependence criteria
across the four substances, we elected to use a single
factor confirmatory model and did not conduct explora-
tory analyses, in addition to limiting the factor analysis to
the dependence criteria to exclude abuse. All individuals
with DSM-IV criteria data were utilized, regardless of age
or substance use. The factor score from the resulting
confirmatory analyses was utilized as the quantitative
phenotype.
Heritability was estimated for the two phenotypes
using the polygenic option in SOLAR (Almasy & Blangero
1998). The correlation between the total number of
DSM-IV criteria endorsed (between 0 and 28) and
QUANTDEP was estimated using the Pearson correlation
coefficient. ANOVAwas used to test if QUANTDEP differed
according to the number of substance dependence diag-
nosesmet.We also tested if the average QUANTDEP value
differed across alcohol, cannabis, cocaine and opioid
dependence diagnoses. Post hoc pairwise comparisons
employed a Tukey correction for multiple testing.
Genotyping and association analysis
Genotyping for 2105 subjects in these 118 families was
performed at the Genome Technology Access Center at
Washington University School of Medicine in St. Louis
using the Illumina Human OmniExpress array 12.VI
(Illumina, San Diego, CA, USA). In addition, genotypes
previously generated on the Illumina Human 1M-Duo
BeadChip (Illumina) by the Center for Inherited Disease
Research were included for 224 subjects from these fami-
lies (Edenberg et al. 2010). Further details describing
data cleaning can be found inWetherill et al. (2014). The
final analytic sample included 2322 genotyped individu-
als. This yielded an average of 19.6 genotyped members
per family.
The Genome-Wide Association Analysis with Family
Data package was utilized to analyze ANYDEP, imple-
mented as a logistic regression model. Relatedness
between family members was accounted for via general-
ized estimating equations. QUANTDEP was analyzed
using a linear mixed effects model as implemented in the
kinship library (lmekin) in R (http://www.inside-r.org/
packages/cran/kinship/docs/print.lmekin). This model
in the kinship function allows for the covariance matrix
to be completely specified for the random effects. The
result is that each family has a different covariance
pattern based on the kinship coefficients, to model the
familial genetic random effects. Gender and birth cohort
defined by year of birth (< 1930, 1930–1949, 1950–
1969 and ≥ 1970) were included as covariates in all
analyses described above, including statistical models of
association, to account for secular trends (Grucza et al.
2008). As needed, genomic control was applied to
correct for inflation. To reduce the scope of multiple
testing, only genotyped single-nucleotide polymorphism
(SNPs) were included in the initial analyses. After
correcting for the final number of autosomal SNPs
(n = 591 785), the genome-wide significance threshold
was P = 8.45 × 10−8.
In regions with significant association results, we
analyzed imputed SNPs to further evaluate the evidence
for association. SNPs were imputed to 1000 genomes
(EUR, August 2010 release) using BEAGLE 3.3.1
(Browning & Browning 2009) as described in Wang
et al. (2013). Secondary analyses were performed for
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significant SNPs to test whether the observed genetic
association could be attributed to dependence on a spe-
cific substance. Analyses for ANYDEP were performed
using the Mantel–Haenszel χ2 test of association assum-
ing an additive genetic model. Analyses for QUANTDEP
were performed using analysis of covariance employing
substance, genotype, and the substance × genotype inter-
action to test for differences in genotype by substance.
Gender and birth cohort were included as covariates.
Replication study
Independent replication of SNPs demonstrating evidence
of significant association in the COGA sample was evalu-
ated in the Study of Addiction: Genetics and Environment
(SAGE) sample. SAGE is a case-control sample comprised
of three complementary studies: COGA, the Family Study
of Cocaine Dependence and the Collaborative Genetics
Study of Nicotine Dependence (Bierut 2010). There were
129 individuals from the 118 COGA families in the
current study that overlapped with the SAGE sample, and
were removed from the SAGE replication dataset. The
remaining independent SAGE sample used for replication
was limited to 2647 individuals of European-American
descent. Factor analysis scores from Mplus were inde-
pendently estimated for this study, as described above,
based on DSM-IV dependence criteria for the four sub-
stances. Analyses were implemented in Plink (Purcell
et al. 2007; http://pngu.mgh.harvard.edu/purcell/plink)
and included age at interview and gender as covariates.
RESULTS
ANYDEP
The number of individuals utilized for the categorical
phenotype ANYDEP was 1770 (59% male). Summary
results are provided only for genotyped individuals for
both phenotypes. Nearly half the sample met the DSM-IV
criteria for at least one substance (ANYDEP, n = 832,
47%). The COGA sample was ascertained through an
alcohol-dependent individual in treatment and families
were selected for the highest density of alcohol-
dependent members; therefore, it was expected that there
would be many individuals meeting criteria for alcohol
dependence (40% in the full sample, but 84% of those
who were dependent on alcohol and/or any other sub-
stance). In addition, 19% met criteria for cannabis
dependence (with or without alcohol dependence). The
rates for cocaine and opioid dependence were lower (11%
and 4%, respectively). There were 832 individuals that
met criteria for at least one substance dependence diag-
nosis; of those, 312 (37.5%) endorsed at least two diag-
noses. Alcohol and cannabis dependence were the most
common (15%; Table 1).
QUANTDEP
The number of individuals included in the analysis of the
quantitative factor score QUANTDEP was 2,183 (47%
male). The confirmatory one-factor model fits the data
well in COGA [comparative fit index (CFI) = 0.96; root
mean square error of approximation (RMSEA) = 0.07],
and in the replication sample, SAGE (CFI = 0.98;
RMSEA = 0.07), supporting our proposed unidimensio-
nal conceptualization of dependence criteria for alcohol,
cannabis, cocaine and opioids. Factor loadings in the
COGA sample ranged from 0.67 (alcohol dependence cri-
terion desire to cut down) to 0.99 (for several cocaine
dependence criteria) and were highly consistent across
COGA and SAGE. In general, factor loadings for alcohol
and cannabis dependence criteria were lower, and ranged
between 0.67 and 0.85, while those for cocaine and
opioids were uniformly high (0.84–0.99). Data across
drug classes and across criteria loadings (and standard
errors) for all seven criteria for the four substances are
available in Supporting Information Fig. S1.
ANYDEP and QUANTDEP
As expected, individuals with no substance dependence
had the lowest QUANTDEP values [mean = −0.40, stand-
ard error (SE) = 0.01] and those with a dependence
Table 1 Substance dependence for the 832 genotyped individu-
als meeting any criteria for DSM-IV substance dependence.
No. of
affected
% affected of
all affected
Substance
Any alcohola 696 83.6
Any cannabisa 331 39.7
Any cocainea 182 22.4
Any opioidsa 72 8.9
Patterns of substance dependence
co-morbidity
Alcohol alone 405 48.7
Cannabis alone 85 10.2
Cocaine alone 23 2.8
Opioids alone 7 0.8
Alcohol + cannabis 126 15.1
Alcohol + cocaine 40 4.8
Alcohol + opioids 15 1.8
Cannabis + cocaine 14 1.7
Cannabis + opioids 2 0.2
Cocaine + opioids 1 0.1
Alcohol + cannabis + cocaine 67 8.0
Alcohol + cannabis + opioids 10 1.2
Alcohol + cocaine + opioids 10 1.2
Cannabis + cocaine + opioids 4 0.5
Alcohol + cannabis + cocaine + opioids 23 2.8
Total 832 100%
aIncludes co-morbid individuals.
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diagnosis for all four substances had the highest
QUANTDEP values [mean = 1.45, SE = 0.06; overall F(8,
1762) = 659.4, P < 0.0001; all pairwise Tukey-adjusted
P < 0.006] (Fig. 1a). QUANTDEP values differed based on
the substance [overall F(7,502) = 32.9, P < 0.0001; all
pairwise Tukey-adjusted P < 0.03], with individuals
meeting cocaine dependence criteria having the highest
mean QUANTDEP scores and those meeting criteria for
alcohol dependence having the lowest (Fig. 1b) of indi-
viduals meeting criteria for dependence on any sub-
stance. QUANTDEP was positively correlated with the
total number of DSM-IV criteria endorsed across the four
substances (rho = 0.88, P < 0.0001).
Genetic analysis
The ANYDEP phenotype was moderately heritable, with
an estimate of 0.54 (standard error = 0.08, P = 1.3 ×
10−17). Heritability for the QUANTDEP was higher, with
an estimate of 0.86 (SE = 0.02, P = 2.1 × 10−66).
Association analyses results are summarized in Fig. 2.
All association results with P < 1.0 × 10−6 are shown in
Table 2. More extensive results are provided in Support-
ing Information Table S1. The QQ plot for ANYDEP
revealed inflation of P-values (λ = 1.0608); therefore,
genomic control (GC) P-values were calculated. The
lambda for the inflation-corrected P-values = 0.99999,
indicating no further inflation. All P-values reported for
ANYDEP are GC P-values. There was no evidence to
suggest inflation of the association P-values for
QUANTDEP (QUANTDEP λ = 1.0095). QQ plots are pro-
vided for each phenotype (Supporting Information
Fig. S2).
Two genotyped SNPs reached genome-wide signifi-
cance (P < 8.4 × 10−8). A SNP in the uncharacterized
gene LOC151121 on chromosome 2, rs2952621, was
associated with ANYDEP (P = 1.8 × 10−8; OR = 1.07).
Secondary analysis was performed to test whether this
SNP demonstrated greater evidence of association with a
particular substance. Although more individuals were
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alcohol dependent, the pattern of dependence by geno-
type was similar for all four substances (χ(1)2 = 0.48,
P = 0.49; Fig. 3a), indicating that the associationwas not
driven by dependence on one particular substance. Indi-
viduals with one or two copies of theminor allele (T) were
more likely to be dependent on at least one substance
than those having no copies of the minor allele. Analysis
of imputed SNPs in this region provided additional evi-
dence to support the association (Fig. 4a). There was
modest replication for this SNP in the SAGE sample
(P = 0.02, OR = 1.1), with T as the risk allele in both
samples. Corresponding SAGE results for the SNPs are
provided in Table 2.
The second genome-wide significant finding was
observed with QUANTDEP and a genotyped SNP
rs2567261 on chromosome 18 in the gene ARHGAP28
(Rho GTPase-activating protein 28) (P = 3.8 × 10−8).
Due to the low minor allele frequency (MAF) for this
SNP (MAF = 0.08), AA and AG genotypes were com-
bined. Although individuals dependent on opioids and
cocaine had higher QUANTDEP scores on average (main
effect of substance P < 0.0001; Fig. 3b), there was no
substance × genotype effect (P = 0.74) confirming that
QUANTDEP exhibited the same pattern by genotype
across the four substances. Analysis of the imputed SNPs
in this region further supported the association (Fig. 4b).
There was no evidence of replication in SAGE for
QUANTDEP (P = 0.29). Corresponding SAGE results for
the SNPs are provided in Table 2.
DISCUSSION
This is one of the first GWAS to test for the association
of overall substance dependence phenotypes, defined
both categorically (dependence diagnosis for alcohol,
cannabis, cocaine or opioids; ANYDEP) and quantita-
tively (factor analysis of the seven DSM-IV dependence
criteria, across alcohol, cannabis, cocaine and opioids;
QUANTDEP). This approach implicitly tested the hypoth-
esis that there are genes with pleiotropic effects contrib-
uting to dependence on alcohol, cannabis, cocaine and
opioids. Using these multi-substance phenotypes, we
detected genome-wide significant results with SNPs in
two different genes. This finding is consistent with an
extensive twin literature that provides demonstrable
Table 2 Summary of association results for SNPs with P < 10−6 for any trait.
SNPb rs2952621 rs1506807 rs2567261 rs6519647
Chra 2 4 18 22
Positionc 129 998 443 178 317 692 6 868 925 26 713 964
MAFd 0.47 0.25 0.08 0.44
Genee LOC151121 (1 kb) NEIL3 (33 kb) AGA (34 kb) ARHGAP28 SEZ6L
COGA family P-value for ANYDEP 1.77E-08 9.12E-04 3.18E-04 4.62E-07
SAGE P-value for ANYDEP 0.02 0.63 0.08 0.81
COGA family P-value for QUANTDEP 3.85E-05 4.43E-07 3.76E-08 2.71E-04
SAGE P-value for QUANTDEP 0.06 0.90 0.29 0.73
All SAGE results are reported. Genome-wide significant results are in bold.
aChromosome. bSingle nucleotide polymorphism. cChromosomal position (base pairs) based on human genome build 19, dbSNP 137. dMinor allele
frequency estimated on founders. eGene name and distance to nearest gene.
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support for common genetic liability underlying addic-
tion to multiple substances (Tsuang et al. 2001; Kendler
et al. 2003). Furthermore, a previous study in a slightly
different COGA sample demonstrated aggregation of
drug dependence in relatives of alcohol-dependent
probands, even after controlling for co-morbidity in the
probands (Nurnberger et al. 2004).
Genome-wide significant association for ANYDEPwas
observed with a SNP in an uncharacterized gene,
LOC151121 (P = 1.8 × 10−8). Further evidence of asso-
ciation was corroborated by surrounding SNPs, both
genotyped and imputed. Nominal replication was found
in the SAGE sample (P = 0.02) with the same phenotype.
This SNP was moderately associated with QUANTDEP
(P = 3.8 × 10−5) and also with the number of DSM-IV
alcohol dependence criteria endorsed (symptom count)
in another related study with data from the same sample
(P = 7.2 × 10−5; Wang et al. 2013). Similar to the repli-
cation results here, this SNP was nominally associated
with the alcohol dependence symptom count in the SAGE
sample as well (P = 0.014; Wang et al. 2013).
Significant association was also detected with
QUANTDEP for the SNP rs2567261 in ARHGAP28
(P = 3.8 × 10−8). Further evidence of association was
observed with both genotyped and imputed SNPs within
the gene. ARHGAP28 is also known as Rho GTPase-
activating protein 28. GTPase-activating proteins target
GTPases, and are mediated by exposure to alcohol, can-
nabis, cocaine and opioids. For example, Rho1 and Rac
moderate the stimulating and sedative effects of acute
ethanol intoxication in Drosophila (Rothenfluh et al.
2006). Thus, there is strong biological rationale for this
gene as a potential candidate for substance dependence.
Of note, this SNP was modestly associated with ANYDEP
(P = 3.2 × 10−4) in this sample and with previously pub-
lished alcohol symptom count in the COGA family sample
(P = 8.7 × 10−5). However, rs2567261 was not signifi-
cantly associated with alcohol symptom count in the
SAGE sample, although there was a trend in that direc-
tion (P = 0.08;Wang et al. 2013). Although the associa-
tion did not replicate in the SAGE sample for this
phenotype, there was a trend toward association with the
other phenotype, ANYDEP (P = 0.08).This weak replica-
tion for a different phenotype may be due to the fact that
the majority of the SAGE sample was ascertained on
nicotine and cocaine dependence, whereas the COGA
sample was recruited based on an alcohol-dependent
proband and expanded to include the maximum number
of alcohol-dependent family members. The exclusion of
nicotine dependence criteria may have attenuated the
likelihood of replication, given ascertainment for nicotine
dependence in SAGE. Since the SNP association was not
primarily due to alcohol dependence, it is possible that
high rates of co-morbidity in the COGA sample as
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Figure 4 Association results. (a) ANYDEP with genotyped and
imputed SNPs in the region flanking LOC151121; y-axis denotes
the −log10 (P-value) for association. x-axis is the physical position
on the chromosome (Mb).The most significantly associated SNP is
shown in purple.The extent of linkage disequilibrium (as measured
by r2) between each SNP and the most significantly associated
SNP is indicated by the color scale at top right. Larger values of
r2 indicate greater linkage disequilibrium. Genotyped SNPs are indi-
cated as circles, and imputed SNPs by squares. (b) QUANTDEP
with genotyped and imputed SNPs in the region flanking
ARHGAP28. y-axis denotes the −log10 (P-value) for association.
x-axis is the physical position on the chromosome (Mb). The most
significantly associated SNP is shown in purple. The extent of
linkage disequilibrium (as measured by r2) between each SNP and
the most significantly associated SNP is indicated by the color scale
at top right. Larger values of r2 indicate greater linkage disequilib-
rium. Genotyped SNPs are indicated as circles, and imputed SNPs
by squares
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compared with the SAGE sample contributed to the
finding. In addition, the family-based test in the large
COGA families with co-morbidity may have had greater
power to detect the association. QUANTDEP seems to rep-
resent an underlying severity of addiction. As seen in
Fig. 3a, the higher the number of co-morbid diagnoses,
the higher the QUANTDEP scores.
Overall, for the QUANTDEP measure, the loadings for
the alcohol and cannabis criteria appear generalizable to
general population studies (Saha, Chou & Grant 2006;
Lynskey & Agrawal 2007); in contrast, those for cocaine
and opioid dependence are higher (typically >0.9). In
COGA, cocaine (7–12%) and opioid (2–5%) dependence
criteria were less commonly endorsed than those for
alcohol (15–51%) and cannabis (9–19%), with the
former also showing less range in endorsement rates
(i.e. each dependence criterion was equally likely to be
endorsed). In SAGE, cocaine dependence criteria (17–
19%) were somewhat more commonly endorsed than
cannabis (12–18%) dependence criteria, yet the cocaine
criteria had higher loadings than the cannabis criteria,
identical to COGA. For both cocaine and opioids, the
range of prevalence of individual criteria was highly
restricted (e.g. 6–7% for opioid criteria). Thus, in both
COGA and SAGE, the likelihood of endorsement of each
of the seven dependence criteria for cocaine and opioids
was similar while certain alcohol and cannabis criteria
(e.g. tolerance) were endorsed more often than others (e.g.
use dominates life). This may be related to the ascertain-
ment strategy and over-representation of family history
for alcoholism in both samples. Nonetheless, all factor
loadings were high, indicating that QUANTDEP reflects a
general liability to dependence across multiple sub-
stances. In particular, QUANTDEP captures the liability to
cocaine and opioid dependence criteria in these two
studies. Therefore, in addition to being an index of sever-
ity and a measure of general liability to addiction across
alcohol and drugs, QUANTDEP likely also reflects varia-
tion in prevalence and the expected pattern of co-morbid
relationships and co-aggregation across alcohol and drug
dependence criteria in these subjects ascertained on spe-
cific substance dependence.
While the heritability of the binary phenotype of
dependence on any substance was similar in this sample
(h2 = 0.54) to the most common heritability estimate
(h2 = 0.50) reported for any of the four substances from
twin studies (Goldman, Oroszi & Ducci 2005), the herit-
ability for the quantitative phenotype was much higher
(h2 = 0.86). This is consistent with one prior twin study of
a latent genetic factor (h2 = 0.81) underlying alcohol and
drug problems as well as measures of impulsivity and
conduct problems (Krueger et al. 2002) but significantly
higher than some others (e.g. h2 = 0.40; Button et al.
2009). Although this high heritability should not be
over-interpreted (Goldman et al. 2005), it is possible that
the use of a multi-variable quantitative phenotype, utiliz-
ing the pattern of endorsement of the seven DSM-IV cri-
teria across all four substances, captured valuable genetic
information across the vulnerability spectrum.
The two phenotypes used in this study were both
aggregate measures of overall dependence. Although
their top genetic signals did not overlap (i.e. the same SNP
did not reach statistical significance for both phenotypes),
there was evidence of association for the other phenotype
for the two SNPs that attained genome-wide significance
(see Supporting Information Table S1 for additional com-
parisons). The difference in magnitude of P-value is not
surprising given the arguable validity of the diagnostic
cutoff (i.e. three ormore of the seven dependence criteria)
implemented in DSM-IV, which likely excluded from
affected status (for ANYDEP), a number of individuals
who may have met criteria for abuse or endorsed 1–2
dependence symptoms across one or evenmultiple drugs,
and thus did not qualify for dependence. Viewed alterna-
tively, the unaffected individuals for ANYDEP represent a
heterogeneous group varying in severity. Such variability
was better captured by QUANTDEP, which while not
taking abuse criteria into account, was a better approxi-
mation of the range of vulnerability to substance-related
problems. Thus, it is likely that ANYDEP reflects the more
severe of the QUANTDEP scores. Finally, the possibility
that our findings reflect false positives cannot be
excluded.
There have been multiple prior GWAS that have uti-
lized symptom counts and factor scores of alcohol
dependence criteria (Yang et al. 2012; Vrieze et al. 2014)
but only one attempted to combine indices of alcohol
(consumption and dependence), nicotine and drug
misuse (with disinhibition measures) using hierarchical
factorial analyses for GWAS. In that study, McGue and
colleagues (McGue et al. 2013) reported on four SNPs
associated with multiple first-order (e.g. alcohol con-
sumption, alcohol dependence, illicit drug dependence)
and higher order externalizing factors. One of these
SNPs, rs10037670 in GALNT10, with the highest asso-
ciation for illicit drug dependence factor (P = 3.8 × 10−6)
was modestly associated in this study with both ANYDEP
(P = 0.0029) and QUANTDEP (P = 0.0067).
There are several strengths of this study design, the
first being the use of families densely affected with
alcohol-dependent individuals. Family (Merikangas et al.
1998; Nurnberger et al. 2004) and twin (Tsuang et al.
1998) studies suggest familial co-aggregation and herit-
able overlap across alcohol, cannabis, cocaine and
opioids. Thus, this family-based COGA sample, enriched
for dependence on multiple substances and shared
genetic risk, allowed us to test for the association of
common variants with risk for dependence across
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multiple substances. A second strength of this study was
the use of a family-based association design. This allowed
us to examine association within a family consisting of
members who endorsed criteria for dependence on differ-
ent (or multiple) substances. Third, family-based analysis
is robust to population substructures such as nuanced
differences in ethnicity, whichmight occur withmarry-in
individuals of a different race, and in turn, affects the
genetic diversity of the offspring.
Three caveats are worth considering. First, only a
small subset of individuals met DSM-IV criteria for opioid
and cocaine dependence. Thus, it is possible that results
pertain more closely to lower liabilities to these sub-
stances. Second, we did not include nicotine dependence
criteria in this analysis. As we were interested in a con-
firmatory model of unidimensional genetic risk, we
elected to exclude nicotine symptoms based on published
evidence for a preponderance of non-overlapping genetic
influences on these criteria. Finally, we elected not to
utilize abuse criteria (nor craving), despite DSM-5-related
changes. Previous findings in COGA families demon-
strated that abuse did not aggregate in relatives of
alcohol-dependent probands (Nurnberger et al. 2004). In
addition, the extant psychometric literature suggests that
with the exception of hazardous use, which is frequently
endorsed to the exclusion of other abuse or dependence
criteria, the remaining abuse criteria (failure to fulfill
role obligations and social/interpersonal problems) and
craving are infrequently endorsed in the absence of
co-occurring dependence criteria. This is particularly
true in samples ascertained for substance use disorders,
such as SAGE and COGA. For instance, in SAGE, of those
who reported no alcohol dependence criteria, only 12–26
individuals endorsed at least one abuse criterion other
than hazardous use (whichwas endorsed by 140). Hence,
it is unlikely that the exclusion of abuse criteria resulted
in our inability to capture a relevant portion of the liabil-
ity continuum.
In summary, this study provides evidence that there
are common variants that contribute to the risk for a
general liability to substance dependence, defined quali-
tatively and quantitatively. The results of this study
require replication in independent samples to further
explore whether overall dependence on multiple or indi-
vidual substances is associated with the SNPs in these
regions.
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